search
precision medicine
Trends
- 1New Blood Test Distinguishes Bacterial and Viral Infections in Newborns▼Blood Test Differentiates Bacterial and Viral Infections in Newborns
A new blood test can differentiate between bacterial and viral infections in newborns, according to a report by Inside Precision Medicine. The development could help doctors decide when antibiotics are truly needed in infants, where diagnosing infection has long been difficult and often leads to precautionary antibiotic use. The finding is drawing attention in medical and precision diagnostics circles.
- 2Study Finds Proliferative Pause Could Help Prevent Brain Metastasis▼Proliferative Pause Reveals Window to Prevent Brain Metastasis
Researchers report that a 'proliferative pause' — a dormant phase cancer cells enter before spreading — may offer a critical window to intervene and stop brain metastasis before it takes hold. The findings, covered by Inside Precision Medicine, suggest targeting cells during this quiet period could prevent secondary brain tumours, a major cause of death in patients with advanced cancers such as breast cancer and melanoma.
- 3Nanomedicine to drive next generation of precision medicine, says Jitendra Singh▼Nanomedicine to drive next generation of precision medicine and personalised healthcare: Jitendra Singh
Indian Science and Technology Minister Jitendra Singh said nanomedicine will drive the next generation of precision medicine and personalised healthcare. He positioned nano-scale drug delivery and diagnostics as key to tailoring treatment to individual patients. The remarks were carried by DD News, highlighting India's push into emerging medical technologies.
- 4UChicago Medicine Names Precision Medicine Leader Josh Denny to Senior Role●UChicago Medicine Appoints National Precision Medicine Leader Josh Denny to New Senior Leadership Role | Newswise
UChicago Medicine has appointed Josh Denny, a nationally recognized leader in precision medicine, to a new senior leadership position. The announcement, distributed via Newswise, signals the academic health system's intent to strengthen its focus on precision medicine, which tailors treatment to individual patients based on genetics and other data. Details on his exact title and start date were not provided in the brief announcement.
- 5Liquid Biopsies Reshape Precision Medicine▼Liquid Biopsies Reshape Precision Medicine: Lori Brisbin, MS, MLS
Lori Brisbin, MS, MLS, discusses how liquid biopsies are changing precision medicine. The blood-based tests, which detect tumor DNA and other biomarkers without invasive procedures, are increasingly used to diagnose cancers, guide treatment choices, and monitor disease. Commentators in managed care circles are weighing the technology's clinical benefits against questions of cost, reimbursement, and broader adoption in routine practice.
- 6
Researchers suggest that analyzing just twenty seconds of a person's speech could help detect diabetes, according to a report by Inside Precision Medicine. The claim points to voice-based screening as a potential low-cost, non-invasive diagnostic tool, though details on the underlying study, its accuracy, and the team behind it were not provided in the available coverage.
- 7Retatrutide Shows Record Weight Loss in Type 2 Diabetes Trial▼Triple Agonist Retatrutide Pushes Weight Loss to New Levels in Type 2 Diabetes
Eli Lilly's triple agonist retatrutide has been reported to push weight loss to new levels among patients with type 2 diabetes, according to Inside Precision Medicine. The drug, which targets three hormone receptors, is being studied as one of the most powerful obesity and diabetes treatments in development, extending gains seen with tirzepatide and semaglutide.
- 8
Technology Networks reports that advanced cell models are accelerating progress in precision medicine. The piece describes how improved laboratory models of human cells and tissue allow therapies to be tested against a patient's specific biology, supporting more tailored diagnosis and treatment and moving personalised approaches from promise into clinical practice.
- 9Scientists refine targeting of cell-surface proteins▼Targeting cell-surface proteins with greater precision
News-Medical reports on advances allowing researchers to target cell-surface proteins with greater precision, a development relevant to drug delivery and therapeutic design. Cell-surface proteins are key entry points for medicines, so improved targeting accuracy could mean more effective treatments with fewer side effects. The report has drawn attention from readers following progress in biotechnology and molecular medicine.